demonstration on Plasmapharesis, its definition, indications, contraindication, steps, after care, complications. for Medical, Lab techinicians, AHS, B.Sc & M.Sc Nursing, DGNM & PC BSc (N)
A brief yet comprehensive coverage of ICU role in ECMO cases. Presentation has been prepared in order to help ICU fellows and registrars to understand the importance of their role and to know necessary actions they have to take in case of need.
A brief yet comprehensive coverage of ICU role in ECMO cases. Presentation has been prepared in order to help ICU fellows and registrars to understand the importance of their role and to know necessary actions they have to take in case of need.
Vascular access in Haemodialysis (2).pptxMithunAhmed5
national institute of kidney disease and urology (nikdu)
Dialysis access refers to the creation of an entrance way into the bloodstream so that the blood can be cleansed by the dialysis procedure. It is well established that dialysis cannot be provided without access.
The attainment and maintenance of a single reliable, long-lasting dialysis access with minimal complications continue to be challenging.
Achievement of such an access is associated with optimal patient clinical outcomes, superior quality of life, and minimal costs.
An intensive care unit (ICU), also known as an intensive therapy unit or intensive treatment unit (ITU) or critical care unit (CCU), is a special department of a hospital or health care facility that provides intensive treatment medicine.
Vascular access in Haemodialysis (2).pptxMithunAhmed5
national institute of kidney disease and urology (nikdu)
Dialysis access refers to the creation of an entrance way into the bloodstream so that the blood can be cleansed by the dialysis procedure. It is well established that dialysis cannot be provided without access.
The attainment and maintenance of a single reliable, long-lasting dialysis access with minimal complications continue to be challenging.
Achievement of such an access is associated with optimal patient clinical outcomes, superior quality of life, and minimal costs.
An intensive care unit (ICU), also known as an intensive therapy unit or intensive treatment unit (ITU) or critical care unit (CCU), is a special department of a hospital or health care facility that provides intensive treatment medicine.
It contains indications of blood and blood products and perioperative blood therapy that we usually follow in Aiims Patna ..its is most recent one made in April 2020
Surgery resident postgraduate presentation on the use of blood and products presented dept of surgery, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa State, Nigeria
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
2. DEFINITION
Plasmapheresis is ablood purification
procedure. It involves removal of blood
from the body and its treatment and the
return of components of blood to the
body after the extraction of plasma.
3. PURPOSE
• In an autoimmune disease the immune system attacks the body’s own
tissues. Plasmapheresis is used to remove antibodies from the
bloodstream thereby preventing them from attacking the targets.
• It does not directly affect the immune system’s ability to make antibodies
and therefore offers temporary benefit.
6. CONTRAINDICATIONS
• Hemodynamic instability
• Sepsis
• Conditions causing inability to tolerate fluid shift(anemic patients and
patients with cardiovascular disease)
• Inability to tolerate Central line placement
• Severe hypocalcemia
7. PRINCIPLES
• Principle of centrifugal separation.
Centrifugation is atechnique that helps to separate mixtures by applying
centrifugal force. Centrifugal aspheresis separate plasma from cellular
components based on density.
8. PRINCIPLES CONTD..
• Principle of membrane separation
• The membrane separation process is based on the presence of semi
permeable membranes. The principle is quite simple: the membrane acts
asavery specific filter that will let water flow through, while it catches
suspended solids and other substances. Membrane aspheresis separate
plasma from cellular components based on molecular size.
9. ARTICLES REQUIRED
• Central line set
• Saline flush
Suture
• Scalpel
• Sterile dressing
• Citrate solution
• Pressure bag to attach monitoring
• Automated centrifuge or
semipermeable membrane
• FFPor albumin
Cell separator
• Sterile field, gloves, gown and
mask
11. PRE- PROCEDURE
• Take patient consent
• Good nutrition and plenty of rest to be provided to make the procedure less stressful.
• Discontinue medications asordered by the physician.
• Set up sterile trolley.
• Confirm the placement of Central venous line
• Position the patient in reverse trendelenburg position in accordance with the patient
comfort.
12. PROCEDURE
• Establish acentral venous line ascentral veins allow higher flow rates and
are more convenient for repeat procedures.
• Any hepawin that may be present in each of the two lumina of acentral
venous catheter is removed.
• Laboratory studies including complete blood count (CBC), calcium and
fibrinogen are ordered and specimens are sent from the draw lumen.
13. PROCEDURE CONTDD..
• A flush with 10ml of normal saline is placed in adraw lumen.
• The draw and return lumen are then connected to the tubing, which is
previously primed with normal saline; however if the patient weighs less
than 20 kilograms then the draw and return tubing is primed with packed
red blood cells instead of normal saline.
• The total blood volume is then estimated from the height and weight of
the patient.
14. PROCEDURE CONTD...
• Plasma volume is then calculated asfollows:
. TBV×(1-hematocrit)
• Are replacement product is chosen.
• The total volume of the desired replacement product is enetred- usually
either 1plasma volume(40ml/kg) or 1.5 plasma volume(60ml/kg).
• A centrifuge speed is determined by the software on the basis off the data
entered.
15. PROCEDURE CONTD ..
• The device then draws whole blood through the draw lumen to the
centrifuge.
• Plasma is then separated buy the centrifuge and then collected for discard.
• RBCs are also separated buy the centrifuge, then returned to the patient
along with the previously selected colloid of either albuminor fresh frozen
plasma(FFP).
16. PROCEDURE CONTD...
• After the desired amount of plasma is removed, the machine is
disconnected from the patient and heparin is instilled into each catheter
lumen to prevent clotting until the lumen is accessed again.
• A post plasma exchange fibrinogen level is checked if albumin was used as
the replacement product to assesswhether the patient has become
severely hyperfibrinogenemic
20. AFTERCARE
• The patient may experience dizziness, nausea, numbness, tingling or
lightheadedness during or after the procedure.
• These effects usually pass quickly allowing the patient to return to normal
activities the same day.